PanGenomic Health (XCNQ:NARA) EPS (Basic): C$-0.21 (TTM As of Mar. 2026)


XCNQ:NARA PanGenomic Health Inc XCNQ:NARA
34 GF Score
Price C$0.37
! 3 Warning Signs
View Full Analysis

What is PanGenomic Health EPS (Basic)?

PanGenomic Health XCNQ:NARA +15.63% 34 EPS (Basic) is C$-0.21 as of Mar. 2026. GuruFocus rates XCNQ:NARA with a GF Score™ of 34/100. The stock has 3 warning signs investors should review.

PanGenomic Health's basic earnings per share (Basic EPS) for the three months ended in Mar. 2026 was C$-0.04. Its basic earnings per share (Basic EPS) for the trailing twelve months (TTM) ended in Mar. 2026 was C$-0.21.

PanGenomic Health's EPS (Diluted) for the three months ended in Mar. 2026 was C$-0.04. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 was C$-0.21.

PanGenomic Health's EPS without NRI for the three months ended in Mar. 2026 was C$-0.04. Its EPS without NRIearnings per share without non-recurring items for the trailing twelve months (TTM) ended in Mar. 2026 was -0.21.

During the past 3 years, the average EPS without NRI Growth Rate was 61.60% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.

During the past 5 years, PanGenomic Health's highest 3-Year average EPS without NRI Growth Rate was 61.60% per year. The lowest was 37.70% per year. And the median was 49.65% per year.

PanGenomic Health  (XCNQ:NARA) EPS (Basic) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.

PanGenomic Health EPS (Basic) Related Terms

PanGenomic Health EPS (Basic) Historical Data

* Premium members only.

The historical data trend for PanGenomic Health's EPS (Basic) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

PanGenomic Health EPS (Basic) Chart

PanGenomic Health Annual Data
Trend Dec21 Dec22 Dec23 Dec24 Dec25
EPS (Basic)
-3.39 -10.95 -1.49 -0.82 -0.19

PanGenomic Health Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
EPS (Basic) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.06 -0.03 -0.11 -0.03 -0.04
XCNQ:NARA
34GF Score
PanGenomic Health Inc XCNQ:NARA
EPS (Basic) is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

PanGenomic Health EPS (Basic) Calculation

EPS (Basic) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Basic earnings per share (EPS) do not factor in the dilutive effects on convertible securities.

PanGenomic Health's Basic EPS for the fiscal year that ended in Dec. 2025 is calculated as

Basic EPS (A: Dec. 2025 )=(Net Income-Preferred Dividends)/Shares Outstanding (Basic Average)
=(-3.431-0)/18.434
=-0.19

PanGenomic Health's Basic EPS for the quarter that ended in Mar. 2026 is calculated as

Basic EPS (Q: Mar. 2026 )=(Net Income-Preferred Dividends)/Shares Outstanding (Basic Average)
=(-0.926-0)/25.600
=-0.04

EPS (Basic) for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was C$-0.21

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EPS (Basic) →
What does a EPS (Basic) of C$-0.21 mean?
PanGenomic Health (XCNQ:NARA) has a EPS (Basic) of C$-0.21 as of Mar. 2026. Earnings per share (basic) equals net income divided by the standard, non-diluted average shares outstanding. View historical data on PanGenomic Health and its competitors.
Is PanGenomic Health's EPS (Basic) too high?
PanGenomic Health's current EPS (Basic) is C$-0.21. Overall, PanGenomic Health has a GF Score™ of 34/100, reflecting its overall financial health beyond just this single metric.
How does PanGenomic Health's EPS (Basic) compare to VEEV and BTSG?
PanGenomic Health's EPS (Basic) of C$-0.21 can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EPS (Basic) for a Healthcare Providers & Services company?
A good EPS (Basic) depends on the Healthcare Providers & Services industry context. However, EPS (Basic) should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EPS (Basic) mean?
A high EPS (Basic) can signal that a stock is expensive relative to its fundamentals. Earnings per share (basic) equals net income divided by the standard, non-diluted average shares outstanding. View historical data on PanGenomic Health and its competitors. PanGenomic Health's current EPS (Basic) is C$-0.21. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PanGenomic Health stock overvalued right now?
PanGenomic Health (XCNQ:NARA) has a current EPS (Basic) of C$-0.21. The current EPS (Basic) is C$-0.21. PanGenomic Health's overall GF Score™ is 34/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EPS (Basic) calculated?
EPS (Basic) is calculated from a company's financial statements. For PanGenomic Health (XCNQ:NARA), the current EPS (Basic) is C$-0.21 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

PanGenomic Health Business Description

Other Exchanges LL3:Germany
Address 200 - 1575 W. Georgia Street, Vancouver, BC, CAN, V6G 2V3
PanGenomic Health Inc is focused on providing a technology platform that identifies plant-based solutions tailored to the health profile of each individual. Along with its subsidiaries, it is developing a self-care digital platform to deliver personalized, evidence-based information about natural treatments to support a user's specific health needs. Its initial focus is to provide information on personalized natural mental health solutions. The core products in production and under development by the company and its subsidiaries are a mobile app for consumers, Nara; an eCommerce website for consumers, Agenta Health; a real-world evidence platform for the complementary and alternative medicine market, Mindleap; and a clinical decision support platform for health practitioners, MUJN.
34GF Score

Get the complete analysis for XCNQ:NARA

EPS (Basic) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

C$0.37
Price